CD4 and neoplasm: It was also noted that the levels of PMN‐MDSCs and Mo‐MDSCs subsets in MDSCs and the levels of CD4+ T and CD8+ T subsets in CD3+ T cells did not change in PBMCs of tumor‐bearing mice treated with NU7441 (Figure S5A–D).